CoronaCentral

  • Dashboard

  • Trending

  • Epidemiology
    Forecasting & Modelling
    Infection Reports
    Transmission
    Contact Tracing
    Prevalence
    Prevention
    Surveillance
  • Clinical
    Clinical Reports
    Risk Factors
    Long Haul
    Pediatrics
    Medical Specialties
    Recommendations
    Imaging
    Diagnostics
    Healthcare Workers
  • Biology
    Molecular Biology
    Immunology
    Model Systems & Tools
    Non-human
  • Treatment
    Therapeutics
    Drug Targets
    Vaccines
    Clinical Trials
    Medical Devices
  • Psychology
  • Policy
    Health Policy
    Communication
    Inequality
    Education
  • Other Articles
    Reviews
    Meta-analysis
    Comments & Editorials
    CDC Weekly Reports
    Book Chapters
    News
    Non-medical
    Retractions
    Misinformation

  • Mentions
    Drugs
    Genes or Proteins
    Genetic Variation
    Locations
    Medical Specialties
    Prevention Methods
    Risk Factors
    Species
    Symptoms
    Test Types
    Transmission Types
    Vaccine Types
    Viral Lineages

  • FAQs
  • Feedback

Drug Targets

Share
Research discussing potential therapeutic coronavirus targets
Published and Preprint Papers
Filter
Title
Altmetric
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

The SARS-CoV-2 main protease M pro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.

The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Project funded by the Chan Zuckerberg Biohub and NLM grant LM05652